ABEO Abeona Therapeutics Inc

Biotech stocks offer investors a clear risk/reward proposition. Investors should look at the company’s clinical focus and its pipeline. This clinical-stage immuno-oncology company’s stock is up over 135% after announcing updated interim data in a Phase 1 trial for its leading therapeutic. This pre-clinical company is surging as investors are beginning to speculate on the […]
https://www.valuewalk.com/three-small-cap-biotech-stocks-to-consider-now/